(2015)
Pseudomonas aeruginosa uses dihydrolipoamide dehydrogenase (Lpd) to bind to the human terminal pathway regulators vitronectin and clusterin to inhibit terminal pathway complement attack.
PLOS One 10(9),
e0137630.
Prof. Dr. Christine Skerka
AlumniPublikationen
(2015)
Sequence variations and protein expression levels of the two immune evasion proteins Gpm1 and Pra1 influence virulence of clinical candida albicans isolates.
PLOS One 10(2),
e0113192.
(2015)
Atypical aHUS: State of the art.
Mol Immunol 67(1),
31-42.
(Review)
(2015)
Complement the alternative pathway.
Encyclopedia of Life Sciences; John Wiley & Sons, Ltd, Chichester
[In press]
(2015)
The role of complement in C3 glomerulopathy.
Mol Immunol 67(1),
21-30.
(2014)
Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
J Clin Invest 124(1),
145-155.
(2014)
Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.
Infect Immun 82(1),
380-392.
(2014)
Virulent strain of Lichtheimia corymbifera shows increased phagocytosis by macrophages as revealed by automated microscopy image analysis.
Mycoses 57(Suppl. 3),
56-66, */⁺authors contributed equally.
(2014)
Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin.
PLOS One 9(3),
e90796.
(2014)
New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases.
Mol Immunol 62(1),
235-248.